Suppr超能文献

微乳原位离子敏感凝胶鼻腔给药系统的配方与评价。

Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin.

机构信息

Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan, China.

出版信息

J Drug Target. 2012 Dec;20(10):831-40. doi: 10.3109/1061186X.2012.719230. Epub 2012 Aug 31.

Abstract

The purpose of our study was to develop a microemulsion-based in situ ion-sensitive gelling system for intranasal administration of curcumin. A new microemulsion composition for curcumin was optimized with the simple lattice design. And the microemulsion-based in situ ion-sensitive gelling system consisted of Capryol 90 as oil phase, Solutol HS15 as surfactant, Transcutol HP as cosurfactant and 0.3% DGG solution as water phase. The physicochemical properties such as morphology, droplet size distribution, zeta value and the in vitro release were investigated. In addition, the histological section studies on the reaction between the obtained formulation and nasal mucosa showed that the microemulsion-based in situ ion-sensitive gelling system could not produce obvious damage to nasal mucosa. The pharmacokinetics results showed that the absolute bioavailability of curcumin in the microemulsion-based in situ ion-sensitive gelling system was 55.82% by intranasal administration. And the brain targeting index (BTI) was 6.50, and in the tissue distribution experiment, the value of (AUC(brain)/AUC(blood)) following intranasal administration was higher than that following intravenous administration, suggesting that the obvious brain targeting property by nasal delivery be attributed to a direct nose-to-brain drug transport. It can be concluded that the microemulsion-based in situ gelling as an effective and safe vehicle could greatly enhance the in vivo absorption and facilitate the delivery of curcumin to brain by intranasal administration.

摘要

本研究旨在开发一种基于微乳的原位离子敏感胶凝系统,用于姜黄素的鼻腔给药。采用简单的格子设计优化了姜黄素的新微乳配方。基于微乳的原位离子敏感胶凝系统由癸酰基 90 作为油相、聚山梨醇酯 HS15 作为表面活性剂、Transcutol HP 作为助表面活性剂和 0.3%的 DGG 溶液作为水相组成。考察了形态、粒径分布、Zeta 值和体外释放等物理化学性质。此外,对获得的制剂与鼻黏膜之间反应的组织学切片研究表明,基于微乳的原位离子敏感胶凝系统不会对鼻黏膜产生明显的损伤。药代动力学结果表明,鼻腔给予姜黄素微乳原位离子敏感胶凝系统的绝对生物利用度为 55.82%。脑靶向指数(BTI)为 6.50,在组织分布实验中,鼻腔给药后(AUC(脑)/AUC(血))的值高于静脉给药后,表明鼻腔给药具有明显的脑靶向特性,这归因于直接的鼻-脑药物传递。可以得出结论,基于微乳的原位胶凝系统作为一种有效且安全的载体,可以大大增强体内吸收,并通过鼻腔给药促进姜黄素向脑内的递送。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验